Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp

<< Previous

Bullboard Posts

Next >>

Post by subaru1ion Apr 02, 2024 1:18pm

79 Views

Post# 35965562

mdj....CBG...I will remind you....

CBG for localized pain and inflammation...that is coming from LABS and their development of CBG was announced in late 2022 or early 2023.

.....how does Avicanna CBG products meet regulatory requirements into Germany and Australia markets? >>>>Medipharm Labs, expanded strategic manufacturing agreement...CDMO

<< Previous

Bullboard Posts

Next >>

PharmAla Biotech launches educational portal for MDMA